Compare PLRX & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLRX | DXYZ |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 447.0M |
| IPO Year | 2020 | 2024 |
| Metric | PLRX | DXYZ |
|---|---|---|
| Price | $1.24 | $32.17 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $3.79 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | N/A |
| Earning Date | 11-06-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.10 | N/A |
| 52 Week High | $14.26 | N/A |
| Indicator | PLRX | DXYZ |
|---|---|---|
| Relative Strength Index (RSI) | 39.33 | 59.00 |
| Support Level | $1.20 | $30.07 |
| Resistance Level | $1.27 | $33.62 |
| Average True Range (ATR) | 0.06 | 3.15 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 25.81 | 37.17 |
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.